NAYA Biosciences, Inc. (NAYA) Stock
INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About NAYA Biosciences, Inc.
INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.
NAYA Biosciences, Inc. is headquartered in US.
NAYA Biosciences, Inc. (NAYA) stock trades at $2.20 with a market capitalization of $1.47M. The stock is valued at a price-to-earnings (P/E) ratio of -0.07, price-to-book of 0.05, price-to-sales of 0.22. Over the past 52 weeks the stock has ranged between $1.38 and $17.04, and currently trades 87.1% below its 52-week high.
On profitability, NAYA Biosciences, Inc. generates a return on equity (ROE) of -133.37%, return on capital employed of -28.49%, an operating margin of -124.40%, a net profit margin of -139.25%.
Official website: www.nayabiosciences.com